Developing actionable steps to promote appropriate prescribing for individuals with acute and chronic pain is imperative to curbing the impact of the growing opioid crisis facing our communities.
This 3-part online series reflects the insights and guidance from experts in pain medicine, primary care, addiction, orthopedic surgery, oral surgery, the physician assistant community, and the DEA Educational Foundation. Part 1 is focused on the pain landscape, including the different types of pain and pain pathways, the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain, non-pharmacologic options for managing pain, and tools for evaluating addiction risk. The goal is to provide best practice strategies for clinicians who encounter and manage patients with acute and chronic pain.
At the end of this CME/CE activity, participants should be able to:
The following learning objectives pertain only to those requesting CNE or CPE credit:
Supported by an educational grant from Johnson & Johnson.
Physicians, dentists, physician assistants, nurse practitioners, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Gold has no disclosures to report.
Dr. Abubaker has no disclosures to report.
Mr. Alden has no disclosures to report.
Ms. Judd reports that she is on the speakers bureau for Alkermes; Neurocrine Biosciences, Inc.; Otsuka America Pharmaceutical, Inc.; Sunovion Pharmaceuticals Inc. She is on the advisory board for ACADIA Pharmaceuticals Inc.; Neurocrine Biosciences, Inc.
Dr. Mir reports that he is a consultant for OrthoGrid Systems, Inc.; Smith & Nephew; StabilizOrtho; Trice Medical; Zimmer Biomet.
Dr. Schmidt has no disclosures to report.
Dr. Stanos reports that he receives research support from Grunenthal and is a consultant for SCILEX Pharmaceuticals, Inc.
Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.